Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival. [electronic resource]
Producer: 20070926Description: 294-9 p. digitalISSN:- 0009-9236
- CD4-Positive T-Lymphocytes -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Chemotaxis, Leukocyte -- drug effects
- Drug Resistance, Viral
- Fas Ligand Protein -- antagonists & inhibitors
- Flow Cytometry
- Gene Products, tat -- antagonists & inhibitors
- Gene Products, vpr -- antagonists & inhibitors
- HIV Envelope Protein gp120 -- toxicity
- HIV Protease Inhibitors -- pharmacology
- HIV-1 -- drug effects
- Humans
- Nelfinavir -- pharmacology
- Receptors, CXCR4 -- antagonists & inhibitors
- TNF-Related Apoptosis-Inducing Ligand -- antagonists & inhibitors
- Virus Replication -- drug effects
- tat Gene Products, Human Immunodeficiency Virus
- vpr Gene Products, Human Immunodeficiency Virus
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.